Filing Details
- Accession Number:
- 0000950117-10-000372
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-23 13:00:00
- Reporting Period:
- 2010-03-19
- Filing Date:
- 2010-03-23
- Accepted Time:
- 2010-03-23 16:35:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 50710 | Javelin Pharmaceuticals Inc | JAV | Pharmaceutical Preparations (2834) | 880471759 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1339402 | J Martin Driscoll | C/O Javelin Pharmaceuticals, Inc. 125 Cambridgepark Drive Cambridge MA 02140 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $.001 | Acquisiton | 2010-03-19 | 22,181 | $1.30 | 236,553 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The 22,181 shares of common stock were purchased in multiple same-way open market transactions at different prices ranging from $1.29 to $1.31. The weighted average purchase price for the shares was $1.3015. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.
- Includes (i) 112,505 shares of common stock, (ii) 5,000 shares of common stock purchased pursuant to the Issuer?s Employee Stock Purchase Plan and (iii) 119,048 Deferred Stock Units (DSUs) granted on May 1, 2009.
Billionaire Hedge Funds
